The Double Standard on Trading Contaminated Chinese and U.S. Consumer Products, Say Dr. Samuel S. Epstein and Ronnie Cummins
Posted on: Monday, 30 July 2007, 15:19 CDT
CHICAGO, July 30 /PRNewswire/ -- The dangers of cheap Chinese exports of contaminated consumer products have received extensive media coverage, besides the formation of a Cabinet-level Product Safety Panel. These exports include personal care products, such as toothpaste contaminated with the anti-freeze diethylene glycol, honey contaminated with dangerous antibiotics, and food contaminated with banned drugs, pesticides and carcinogens. In contrast, Congress and the media remain silent on the export of dangerous U.S. consumer products, besides their decades-old domestic sale.
U.S. personal care and cosmetic products contain a wide range of avoidable toxic ingredients, notably multiple carcinogens, hormones and allergens, which remain unregulated by the FDA. These products include leading brands of toothpaste with carcinogenic ingredients. In sharp contrast, the 30-member state European Union has developed a Cosmetic Directive, which bans the manufacture and import of products suspected of causing harm to human health. Highlighting FDA's indifference is the State of California's 2005 Safe Cosmetic Act, requiring cosmetic companies to disclose information on toxic ingredients.
Of major concern is U.S. milk from cows injected with Monsanto's genetically engineered recombinant bovine growth hormone (rBGH) to increase milk production. According to Monsanto, about one third of dairy cows in the nation are in herds where the hormone is used. This milk contains abnormally high levels of a natural growth factor known as IGF-1. As documented in over 30 scientific publications, detailed in our May 2007 Citizen Petition to the FDA, increased levels of IGF-1 in milk increase risks of breast cancer by up to seven-fold, besides risks of colon and prostate cancers. Not surprisingly, the import of U.S. rBGH dairy products has been banned by Canada, 29 European nations, Norway, Switzerland, Japan, New Zealand, Australia, and South Africa. Also, in June 1999, the United Nations Food Safety Agency, representing 101 nations worldwide, voted unanimously to reject a safety standard for rBGH milk. Nevertheless, there are no FDA restrictions on its continued sale in the U.S., nor any requirement for warning labels.
U.S. beef is heavily contaminated with natural or synthetic sex hormones. When U.S. beef cattle enter feedlots, pellets of these hormones are implanted under the ear skin, a process repeated at the midpoint of their 100-day pre-slaughter fattening period. These hormones increase carcass weight, adding about $80 profit per animal. Not surprisingly, but contrary to the claims of the FDA and USDA, residues of these hormones in meat are up to 20-fold higher than normal. Increased levels of sex hormones are linked to the escalating incidence of reproductive cancers in the U.S. since 1975, 36% for post-menopausal breast cancer, 50% for testicular cancer, and 88% for prostate cancer. Based on these concerns, Europe banned imports of U.S. beef in 1989, and Japan followed up with its own ban in 2003. Before the ban, Japan was the most lucrative overseas market for American beef, importing more than $1.5 billion worth in 2003.
These concerns are not new. As evidenced in a series of General Accounting Office investigations and Congressional hearings, FDA registration and residue-tolerance programs and USDA inspections are in near total disarray, aggravated by brazen denials and cover-ups. A January 1986 report, "Human Food Safety and the Regulation of Animal Drugs," unanimously approved by the House Committee on Government Operations, concluded that "the FDA has consistently disregarded its responsibility -- has repeatedly put what it perceives are interests of veterinarians and the livestock industry ahead of its legal obligation to protect consumers -- jeopardizing the health and safety of consumers of meat, milk and poultry."
Cancer Prevention Coalition; Organic Consumers Association
CONTACT: Samuel S. Epstein, M.D., Professor emeritus, Environmental &Occupational Medicine, University of Illinois at Chicago School of PublicHealth, Chairman of Cancer Prevention Coalition, +1-312-996-2297,epstein@uic.edu; or Ronnie Cummins, National Director of Organic ConsumersAssociation, +1-218-349-3836, ronnie@organicconsumers.org
Source: PRNewswire
Related Articles
- Cancer Advocacy Organization Confronts the Source of rBGH, Demands Pharmaceutical Giant Eli Lilly Stop 'Milking Cancer'
- IGI Laboratories, Inc. Signs Product Development Agreement With Cancer Health Solutions Resources, LLC
- Hollis-Eden Pharmaceuticals Announces Filing of IND With APOPTONE(TM) in Hormone Sensitive Cancers to Commence Phase I/II Clinical Trial in Late-Stage Prostate Cancer
- Hispanic Helpline Offers Information for Consumers and Business Owners on FDA Public Health Action on Contaminated Food and Health Products From China
- PuriCore Plc Announces FDA Lists Sterilox Food Safety Solution for Food Contact
- FDA Plans to Boost Safety With Newsletters, Drug Profiles
- Beef Export Ban is Lifted
- US Again Urges Japan to Lift Beef Import Ban By Year-End
- Gov't to Send Inspectors to U.S., Canada to Check Safety of Beef
- pSivida Expands Market for Lead Cancer Product BrachySil-TM- ; Pancreatic Cancer - Significant Unmet Clinical Need
User Comments (0)

RSS Feeds